• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Smokers with multiple sclerosis are more likely to report comorbid autoimmune diseases.多发性硬化症患者更有可能报告合并自身免疫性疾病。
Neuroepidemiology. 2011;36(2):85-90. doi: 10.1159/000323948. Epub 2011 Feb 1.
2
Cigarette smoking and associated risk of multiple sclerosis in the Iranian population.伊朗人群中吸烟与多发性硬化症相关风险的研究。
J Clin Neurosci. 2013 Dec;20(12):1747-50. doi: 10.1016/j.jocn.2013.01.018. Epub 2013 Aug 20.
3
Diet quality is not associated with late-onset multiple sclerosis risk- A Danish Cohort Study.饮食质量与晚发性多发性硬化症风险无关-一项丹麦队列研究。
Mult Scler Relat Disord. 2020 May;40:101968. doi: 10.1016/j.msard.2020.101968. Epub 2020 Jan 26.
4
Lifetime exposure to smoking and substance abuse may be associated with late-onset multiple sclerosis: a population-based case-control study.终生暴露于吸烟和物质滥用可能与晚发性多发性硬化症有关:一项基于人群的病例对照研究。
BMC Neurol. 2024 Sep 6;24(1):327. doi: 10.1186/s12883-024-03815-9.
5
Smoking status over two years in patients with multiple sclerosis.多发性硬化症患者两年内的吸烟状况。
Neuroepidemiology. 2009;32(1):72-9. doi: 10.1159/000170910. Epub 2008 Nov 12.
6
Gender and autoimmune comorbidity in multiple sclerosis.多发性硬化症中的性别与自身免疫性合并症
Mult Scler. 2014 Aug;20(9):1244-51. doi: 10.1177/1352458514521515. Epub 2014 Feb 5.
7
Smoking is a risk factor for multiple sclerosis.吸烟是多发性硬化症的一个风险因素。
Neurology. 2003 Oct 28;61(8):1122-4. doi: 10.1212/01.wnl.0000081305.66687.d2.
8
Smokers with MS have greater decrements in quality of life and disability than non-smokers.患有多发性硬化症的吸烟者的生活质量和残疾程度下降幅度大于不吸烟者。
Mult Scler. 2017 Nov;23(13):1772-1781. doi: 10.1177/1352458516685169. Epub 2017 Jan 6.
9
Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis.吸烟会增加患多发性硬化症的风险,但使用瑞典鼻烟则不会。
Neurology. 2009 Sep 1;73(9):696-701. doi: 10.1212/WNL.0b013e3181b59c40.
10
Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis.血管合并症与多发性硬化症中更快的残疾进展有关。
Neurology. 2010 Mar 30;74(13):1041-7. doi: 10.1212/WNL.0b013e3181d6b125.

引用本文的文献

1
The impact of autoimmune comorbidities on multiple sclerosis progression: insights from a longitudinal single-center study.自身免疫性合并症对多发性硬化症进展的影响:一项纵向单中心研究的见解
J Neurol. 2025 Sep 3;272(9):607. doi: 10.1007/s00415-025-13351-2.
2
Acute Myocardial Infarction and Diffuse Coronary Artery Disease in a Patient with Multiple Sclerosis: A Case Report and Literature Review.一名多发性硬化症患者并发急性心肌梗死和弥漫性冠状动脉疾病:病例报告及文献综述
J Clin Med. 2025 Jun 17;14(12):4304. doi: 10.3390/jcm14124304.
3
Multiple Sclerosis and Autoimmune Comorbidities.多发性硬化症与自身免疫性共病
J Pers Med. 2022 Nov 3;12(11):1828. doi: 10.3390/jpm12111828.
4
Onset Symptom Clusters in Multiple Sclerosis: Characteristics, Comorbidities, and Risk Factors.多发性硬化症的起病症状群:特征、合并症及危险因素
Front Neurol. 2021 Jul 6;12:693440. doi: 10.3389/fneur.2021.693440. eCollection 2021.
5
Impact of delayed treatment on exacerbations of multiple sclerosis among Puerto Rican patients.延迟治疗对波多黎各患者多发性硬化症病情加重的影响。
Surg Neurol Int. 2019 Oct 11;10:200. doi: 10.25259/SNI_252_2019. eCollection 2019.
6
Symptom Co-occurrences Associated with Smoking in Individuals with Relapsing-Remitting Multiple Sclerosis.复发缓解型多发性硬化症患者中与吸烟相关的症状共现情况。
Int J MS Care. 2016 Jul-Aug;18(4):163-8. doi: 10.7224/1537-2073.2014-028.
7
Increased incidence of rheumatoid arthritis in multiple sclerosis: A nationwide cohort study.多发性硬化症患者类风湿关节炎发病率增加:一项全国性队列研究。
Medicine (Baltimore). 2016 Jun;95(26):e3999. doi: 10.1097/MD.0000000000003999.
8
Prevalence of Comorbidities, Overweight and Obesity in an International Sample of People with Multiple Sclerosis and Associations with Modifiable Lifestyle Factors.国际多发性硬化症患者样本中共病、超重和肥胖的患病率及其与可改变生活方式因素的关联
PLoS One. 2016 Feb 5;11(2):e0148573. doi: 10.1371/journal.pone.0148573. eCollection 2016.
9
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview.对多发性硬化症合并症发病率和患病率的系统评价:概述。
Mult Scler. 2015 Mar;21(3):263-81. doi: 10.1177/1352458514564491. Epub 2015 Jan 26.
10
The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: a systematic review.多发性硬化症中并发胃肠道、肌肉骨骼、眼部、肺部和肾脏疾病的发病率和流行率:系统评价。
Mult Scler. 2015 Mar;21(3):332-41. doi: 10.1177/1352458514564488. Epub 2014 Dec 23.

本文引用的文献

1
Validation of a self-report comorbidity questionnaire for multiple sclerosis.多发性硬化症自报共病问卷的验证。
Neuroepidemiology. 2010 Aug;35(2):83-90. doi: 10.1159/000311013. Epub 2010 Jun 15.
2
The rising prevalence and changing age distribution of multiple sclerosis in Manitoba.曼尼托巴多发性硬化症的发病率上升和年龄分布变化。
Neurology. 2010 Feb 9;74(6):465-71. doi: 10.1212/WNL.0b013e3181cf6ec0. Epub 2010 Jan 13.
3
Smoking status over two years in patients with multiple sclerosis.多发性硬化症患者两年内的吸烟状况。
Neuroepidemiology. 2009;32(1):72-9. doi: 10.1159/000170910. Epub 2008 Nov 12.
4
Comorbidity, socioeconomic status and multiple sclerosis.共病、社会经济地位与多发性硬化症
Mult Scler. 2008 Sep;14(8):1091-8. doi: 10.1177/1352458508092263.
5
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I.美国关节炎及其他风湿性疾病患病率的估计。第一部分。
Arthritis Rheum. 2008 Jan;58(1):15-25. doi: 10.1002/art.23177.
6
Pars planitis: a 20-year study of incidence, clinical features, and outcomes.中间葡萄膜炎:一项关于发病率、临床特征及预后的20年研究。
Am J Ophthalmol. 2007 Dec;144(6):812-817. doi: 10.1016/j.ajo.2007.08.023.
7
The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States.美国克罗恩病和溃疡性结肠炎的患病率及地理分布。
Clin Gastroenterol Hepatol. 2007 Dec;5(12):1424-9. doi: 10.1016/j.cgh.2007.07.012. Epub 2007 Sep 29.
8
Prevalence of autoimmune thyroid disorders in a Spanish multiple sclerosis cohort.西班牙多发性硬化症队列中自身免疫性甲状腺疾病的患病率。
Eur J Neurol. 2007 Sep;14(9):1048-52. doi: 10.1111/j.1468-1331.2007.01882.x.
9
Autoimmune disease in families with multiple sclerosis: a population-based study.多发性硬化症家族中的自身免疫性疾病:一项基于人群的研究。
Lancet Neurol. 2007 Jul;6(7):604-10. doi: 10.1016/S1474-4422(07)70132-1.
10
Validation of the NARCOMS registry: diagnosis.NARCOMS注册库的验证:诊断
Mult Scler. 2007 Jul;13(6):770-5. doi: 10.1177/1352458506075031. Epub 2007 Mar 15.

多发性硬化症患者更有可能报告合并自身免疫性疾病。

Smokers with multiple sclerosis are more likely to report comorbid autoimmune diseases.

机构信息

Department of Internal Medicine, University of Manitoba, Winnipeg, Man., Canada. rmarrie @ hsc.mb.ca

出版信息

Neuroepidemiology. 2011;36(2):85-90. doi: 10.1159/000323948. Epub 2011 Feb 1.

DOI:10.1159/000323948
PMID:21282965
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3047764/
Abstract

BACKGROUND/AIMS: Smoking is a risk factor for multiple sclerosis (MS) and autoimmune disease, and might explain an increased risk of comorbid autoimmune disease (CAD) in MS. We compared the risk of CAD in smokers and nonsmokers with MS.

METHODS

Participants enrolled in the North American Research Committee on Multiple Sclerosis Registry reported their smoking status, the presence of CAD and the year of diagnosis. We used multivariable logistic regression to determine the independent association between smoking and CAD. We also compared the risk of developing a CAD in current smokers versus never-smokers who did not report any CAD at MS onset, using a proportional hazards model.

RESULTS

Among 8,875 participants reporting comorbidities and smoking status, 1,649 (18.5%) reported a CAD. In a multivariable logistic model, ever-smokers had increased odds of reporting a CAD (odds ratio: 1.22; 95% CI: 1.08-1.38). Among the 7,830 participants without a CAD at onset of MS who reported their smoking status, including the age at which they started smoking, 3,035 (36.8%) currently smoked, while 3,805 (48.6%) never smoked. After adjustment, smokers had an increased risk of developing any autoimmune disease (hazard ratio: 1.23; 95% CI: 1.08-1.41) after MS onset.

CONCLUSION

Smoking is associated with an increased risk of CAD in MS.

摘要

背景/目的:吸烟是多发性硬化症(MS)和自身免疫性疾病的危险因素,可能解释了 MS 患者合并自身免疫性疾病(CAD)的风险增加。我们比较了吸烟的 MS 患者和不吸烟的 MS 患者发生 CAD 的风险。

方法

参与北美多发性硬化症研究委员会注册的参与者报告了他们的吸烟状况、CAD 的存在和诊断年份。我们使用多变量逻辑回归来确定吸烟与 CAD 之间的独立关联。我们还使用比例风险模型比较了当前吸烟者与从未吸烟且在 MS 发病时未报告任何 CAD 的非吸烟者发生 CAD 的风险。

结果

在报告合并症和吸烟状况的 8875 名参与者中,1649 名(18.5%)报告了 CAD。在多变量逻辑模型中,曾经吸烟者报告 CAD 的几率增加(比值比:1.22;95%置信区间:1.08-1.38)。在 7830 名在 MS 发病时未报告 CAD 但报告了吸烟状况的参与者中,包括开始吸烟的年龄,3035 名(36.8%)目前吸烟,而 3805 名(48.6%)从不吸烟。调整后,吸烟者在 MS 发病后发生任何自身免疫性疾病的风险增加(风险比:1.23;95%置信区间:1.08-1.41)。

结论

吸烟与 MS 患者 CAD 风险增加相关。